CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Authors
Charlene M. Prazma
Ian D. Pavord
+5 more
Monica Kraft
Peter H. Howarth
Robert G. Price
Roland Buhl
Steven W. Yancey
Publication date
1 May 2022
Publisher
'European Respiratory Society (ERS)'
Doi
Cite
View
on
PubMed
Abstract
In patients with severe eosinophilic asthma and sputum eosinophil counts of ≥3–<30%, sputum eosinophils may not represent a more useful biomarker than blood eosinophils for predicting clinical treatment response to mepolizumab https://bit.ly/3pOTw9
Similar works
Full text
Available Versions
Directory of Open Access Journals
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:doaj.org/article:76317a21f...
Last time updated on 10/06/2023
PubMed Central
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pubmedcentral.nih.gov:9062...
Last time updated on 12/07/2022
